Son DS et al., 2020-08-04: A review of benzimidazole anthelmintics (including fenbendazole) in cancer cell lines and animal models, summarising microtubule disruption, apoptosis, G2/M arrest, anti-angiogenesis and glucose-transport blockade.
In addition to being antiparasitic agents, benzimidazole anthelmintics are known to exert anticancer activities, such as the disruption of microtubule polymerization, the induction of apoptosis, cell cycle (G2/M) arrest, anti-angiogenesis, and blockage of glucose transport.
Son DS et al., 2020-08-04: A review of benzimidazole anthelmintics (including fenbendazole) in cancer cell lines and animal models, summarising microtubule disruption, apoptosis, G2/M arrest, anti-angiogenesis and glucose-transport blockade. C2 Son 2020. Study type: narrative review; N/A; country USA (Meharry Medical College, Nashville); funder NIH U54 CA163069, G12 MD007586, SC1 CA200519, R01 ES024756 and others; conflicts: 'The authors declare no potential conflicts of interest'; maker N/A; comparator N/A. This review supplies most of the '12 mechanisms' phrasing reused by Makis/NaturalNews. Also filed as FBC-42 (claims C2, C8). Study type: review.
